Find slides from real investment banking decks

Browse 137,735 classified slides from investment banking pitch decks.

7,873–7,920 of 137,735 slidesPage 165 of 2870

Framework slide 43 from Akouos — Title Slide

Akouos — Title Slide · Slide 43

2020

Section Divider slide 44 from Akouos — Title Slide

Akouos — Title Slide · Slide 44

2020

Financial Analysis slide 45 from Akouos — Title Slide

Akouos — Title Slide · Slide 45

2020

Framework slide 46 from Akouos — Title Slide

Akouos — Title Slide · Slide 46

2020

Section Divider slide 47 from Akouos — Title Slide

Akouos — Title Slide · Slide 47

2020

Team slide 48 from Akouos — Title Slide

Akouos — Title Slide · Slide 48

2020

Cover slide 1 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 1

Cover slide 2 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 2

Section Divider slide 3 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 3

Case Study slide 4 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 4

Section Divider slide 5 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 5

Team slide 6 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 6

Team slide 7 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 7

Team slide 8 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 8

Team slide 9 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 9

Comparison slide 10 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 10

Comparison slide 11 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 11

Minimal slide 12 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 12

Comparison slide 13 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 13

Team slide 14 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 14

Team slide 15 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 15

Timeline slide 16 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 16

Section Divider slide 17 from Akt Pictures — when I was a human

Akt Pictures — when I was a human · Slide 17

Cover slide 1 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 1

2022

Text slide 2 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 2

2022

Team slide 3 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 3

2022

Cover slide 4 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 4

2022

Chart slide 5 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 5

2022

Text slide 6 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 6

2022

Process slide 7 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 7

2022

Table slide 8 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 8

2022

Chart slide 9 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 9

2022

Chart slide 10 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 10

2022

Chart slide 11 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 11

2022

Text slide 12 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 12

2022

Table slide 13 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 13

2022

Text slide 14 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 14

2022

Team slide 15 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 15

2022

Comparison slide 16 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 16

2022

Comparison slide 17 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 17

2022

Cover slide 18 from Albireo Pharma — ASSERT Topline Data Results

Albireo Pharma — ASSERT Topline Data Results · Slide 18

2022

Cover slide 1 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 1

2022

Text slide 2 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 2

2022

Text slide 3 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 3

2022

Text slide 4 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 4

2022

Comparison slide 5 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 5

2022

Chart slide 6 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 6

2022

Text slide 7 from Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy · Slide 7

2022